Development of Method of Fructose Identification in Urine to Detect the Viral Infection
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01638312 |
Recruitment Status
:
Completed
First Posted
: July 11, 2012
Results First Posted
: October 5, 2015
Last Update Posted
: October 5, 2015
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Human Immunodeficiency Virus |
Study Type : | Observational |
Actual Enrollment : | 50 participants |
Observational Model: | Case Control |
Time Perspective: | Prospective |
Official Title: | The Development of Fast and Simple Method of Fructose Identification in Urine to Detect the Viral Infection in Early Stage |
Study Start Date : | June 2011 |
Actual Primary Completion Date : | May 2013 |
Actual Study Completion Date : | May 2013 |

Group/Cohort |
---|
HIV infection patient and health people
The study does not have intervention
|
- Fructose Identification in Urine to Detect the Viral Infection : Number of Participants With Positive and Negative Waveform [ Time Frame: Participants provided urine samples once ]
This detection technique, after a viral infection caused by the use of cell pathological changes and urine metabolic waste - fructose concentration, derivatives.Health News voltage changes to detect viral pathogens of activity and virulence. Because viral infection caused by the voltage change has its typical, So you can use voltage measurements to calibrate the presence and activity of a viral infection.
1.How to interpretation the data The gap between values on X-axis is σ, and 50 is a reference to the center position. For example, the sample maybe contain with HIV virus if σ≧10 units.
σ≧10 abnormal positive (+) σ<10 normal negative (-)
Biospecimen Retention: None Retained

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Senior |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- HIV infection
Exclusion Criteria:
- who are in highly active antiretroviral therapy(HARRT) therapy

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01638312
Taiwan | |
Tropical Medicine Center, Kaohsiung Medical University Chung-Ho Memorial Hospital | |
Kaohsiung, Taiwan, 807 |
Principal Investigator: | JihJin Tsai, MD | The Medicines Company |
Responsible Party: | Kaohsiung Medical University Chung-Ho Memorial Hospital |
ClinicalTrials.gov Identifier: | NCT01638312 History of Changes |
Other Study ID Numbers: |
KMUH-IRB-20110188 |
First Posted: | July 11, 2012 Key Record Dates |
Results First Posted: | October 5, 2015 |
Last Update Posted: | October 5, 2015 |
Last Verified: | September 2012 |
Keywords provided by Kaohsiung Medical University Chung-Ho Memorial Hospital:
HIV, fructose |
Additional relevant MeSH terms:
Acquired Immunodeficiency Syndrome HIV Infections Immunologic Deficiency Syndromes Virus Diseases Immune System Diseases Lentivirus Infections |
Retroviridae Infections RNA Virus Infections Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Slow Virus Diseases |